Vital Image’s 3-D imaging systems sales soar
The popularity of 3-D imaging systems is rising, and one of the modality’s developers, Vital Images, has sales to prove it.Vital Images’ revenue for first quarter 2000 (ending March 31) rose 30% to $2.3 million from $1.7 million compared to the
The popularity of 3-D imaging systems is rising, and one of the modalitys developers, Vital Images, has sales to prove it.
Vital Images revenue for first quarter 2000 (ending March 31) rose 30% to $2.3 million from $1.7 million compared to the first quarter of 1999. In addition, revenue from software license agreements for first-quarter 2000 increased 40% to $1.5 million from $1.1 million in the same period a year earlier.
The companys losses decreased from a year ago. Vital Images net loss in the first quarter of 2000 was $665,000 compared to $765,000 in the first quarter of 1999.
Vital Images provides 3-D imaging software for use in clinical diagnosis, surgical planning, and screening applications. The company considers Vitrea its flagship product for 3-D imaging. This software program is used for surgical planning and noninvasive diagnostic evaluation of CT and MR images.
Along with new ways to visualize, Vital Images creates tools that automatically measure the blood vessel lumen so as to calculate the size of a stent to be implanted. Last month, Vital Images participated in a symposium in Boston at which major imaging companies addressed the challenges of developing hardware, imaging software, and contrast agents (SCAN 4/26/00).
Vital Images will increase its sales force to keep up with the demand, said Albert Emola, president and CEO.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
